APOE and Parkinson disease: Neither the number of APOE ɛ4 alleles nor PD-associated mutations in LRRK2 were associated with an increased risk of being diagnosed with COVID-19, and the number of APOE ɛ4 alleles and GBA mutations were not associated with new or worsening PD-related symptoms during the pandemic.